11.77
price down icon1.26%   -0.15
after-market Dopo l'orario di chiusura: 11.76 -0.010 -0.08%
loading
Precedente Chiudi:
$11.92
Aprire:
$11.94
Volume 24 ore:
210.49K
Relative Volume:
0.75
Capitalizzazione di mercato:
$258.98M
Reddito:
$52.55M
Utile/perdita netta:
$-23.69M
Rapporto P/E:
-12.52
EPS:
-0.94
Flusso di cassa netto:
$-15.29M
1 W Prestazione:
+6.23%
1M Prestazione:
+29.20%
6M Prestazione:
+163.31%
1 anno Prestazione:
+318.86%
Intervallo 1D:
Value
$11.64
$11.99
Intervallo di 1 settimana:
Value
$10.78
$11.99
Portata 52W:
Value
$2.38
$11.99

Exagen Inc Stock (XGN) Company Profile

Name
Nome
Exagen Inc
Name
Telefono
(760) 560-1501
Name
Indirizzo
1261 LIBERTY WAY, VISTA, CA
Name
Dipendente
209
Name
Cinguettio
@ExagenInc
Name
Prossima data di guadagno
2025-03-11
Name
Ultimi documenti SEC
Name
XGN's Discussions on Twitter

Confronta XGN con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Diagnostics & Research icon
XGN
Exagen Inc
11.77 253.92M 52.55M -23.69M -15.29M -0.94
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
536.78 198.56B 43.21B 6.58B 6.17B 17.28
Diagnostics & Research icon
DHR
Danaher Corp
210.92 147.61B 24.01B 3.41B 4.86B 4.7082
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
637.34 50.96B 4.04B 985.66M 774.34M 12.01
Diagnostics & Research icon
A
Agilent Technologies Inc
141.10 39.13B 6.79B 1.22B 1.09B 4.2644
Diagnostics & Research icon
IQV
Iqvia Holdings Inc
205.75 34.81B 15.70B 1.24B 2.01B 6.9036

Exagen Inc Stock (XGN) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-09-11 Iniziato B. Riley Securities Buy
2025-07-30 Aggiornamento KeyBanc Capital Markets Sector Weight → Overweight
2025-07-23 Iniziato Craig Hallum Buy
2022-08-05 Downgrade KeyBanc Capital Markets Overweight → Sector Weight
2021-10-15 Ripresa Cowen Outperform
2021-04-15 Iniziato Canaccord Genuity Buy
2020-11-10 Iniziato KeyBanc Capital Markets Overweight
2020-10-08 Iniziato BTIG Research Buy
2020-06-02 Ripresa Cantor Fitzgerald Overweight
2019-10-14 Iniziato Cantor Fitzgerald Overweight
2019-10-14 Iniziato Cowen Outperform
2019-10-14 Iniziato William Blair Outperform
Mostra tutto

Exagen Inc Borsa (XGN) Ultime notizie

pulisher
04:42 AM

Strategies to average down on Exagen Inc.Trade Ideas & Weekly Top Gainers Trade List - newser.com

04:42 AM
pulisher
03:51 AM

What to do if you’re stuck in Exagen Inc.July 2025 Highlights & Free Long-Term Investment Growth Plans - newser.com

03:51 AM
pulisher
06:01 AM

There's No Escaping Exagen Inc.'s (NASDAQ:XGN) Muted Revenues Despite A 28% Share Price Rise - 富途牛牛

06:01 AM
pulisher
Oct 15, 2025

Should you hold or exit Exagen Inc. nowWeekly Trade Review & High Conviction Buy Zone Alerts - newser.com

Oct 15, 2025
pulisher
Oct 15, 2025

Will Exagen Inc. stock maintain momentum in 2025July 2025 Market Mood & AI Forecasted Entry/Exit Points - newser.com

Oct 15, 2025
pulisher
Oct 15, 2025

Will Exagen Inc. stock recover faster than peersCEO Change & Weekly Watchlist for Hot Stocks - newser.com

Oct 15, 2025
pulisher
Oct 15, 2025

Will Exagen Inc. stock split attract more investors2025 Stock Rankings & Long-Term Investment Growth Plans - newser.com

Oct 15, 2025
pulisher
Oct 15, 2025

Will Exagen Inc. benefit from macro trendsPortfolio Risk Report & Weekly Chart Analysis and Guides - newser.com

Oct 15, 2025
pulisher
Oct 15, 2025

Has Exagen Inc. formed a bullish divergence2025 Analyst Calls & Free Community Supported Trade Ideas - newser.com

Oct 15, 2025
pulisher
Oct 14, 2025

Exagen (XGN) Gets Maintained 'Overweight' Rating by Keybanc Anal - GuruFocus

Oct 14, 2025
pulisher
Oct 14, 2025

Detecting support and resistance levels for Exagen Inc.Rate Hike & Low Drawdown Investment Strategies - newser.com

Oct 14, 2025
pulisher
Oct 14, 2025

How to build a custom watchlist for Exagen Inc.Price Action & Safe Investment Capital Preservation Plans - newser.com

Oct 14, 2025
pulisher
Oct 14, 2025

How Exagen Inc. stock compares to market leadersPortfolio Return Summary & Expert Approved Momentum Trade Ideas - newser.com

Oct 14, 2025
pulisher
Oct 13, 2025

Analyzing Exagen Inc. with multi timeframe chartsMarket Sentiment Summary & Smart Investment Allocation Tips - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

Earnings visualization tools for Exagen Inc.Market Risk Analysis & High Return Stock Watch Alerts - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

Custom strategy builders for tracking Exagen Inc.Trade Exit Summary & Daily Technical Stock Forecast Reports - newser.com

Oct 13, 2025
pulisher
Oct 12, 2025

Is Exagen Inc. (E08A) stock testing key supportJuly 2025 Levels & Real-Time Chart Breakout Alerts - newser.com

Oct 12, 2025
pulisher
Oct 11, 2025

Exagen’s (XGN) “Sell (D-)” Rating Reiterated at Weiss Ratings - Defense World

Oct 11, 2025
pulisher
Oct 10, 2025

Is Exagen Inc. stock ready for a breakoutInflation Watch & Weekly Stock Breakout Alerts - newser.com

Oct 10, 2025
pulisher
Oct 09, 2025

Does Exagen Inc. show high probability of reboundNew Guidance & Safe Entry Point Alerts - newser.com

Oct 09, 2025
pulisher
Oct 08, 2025

Exagen (NASDAQ:XGN) Earns Sell (D-) Rating from Weiss Ratings - MarketBeat

Oct 08, 2025
pulisher
Oct 07, 2025

What analysts say about Exagen Inc stockMoving Average Crossovers & Affordable Investment Tips - earlytimes.in

Oct 07, 2025
pulisher
Oct 06, 2025

Can Exagen Inc. recover in the next quarterBond Market & Weekly Momentum Stock Picks - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Exagen Inc. (NASDAQ:XGN) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat

Oct 06, 2025
pulisher
Oct 06, 2025

Exagen Inc. recovery potential after sell offBond Market & Reliable Price Breakout Signals - newser.com

Oct 06, 2025
pulisher
Oct 04, 2025

Exagen Inc Stock Analysis and ForecastBullish Engulfing Patterns & Small Budget Capital Investment - earlytimes.in

Oct 04, 2025
pulisher
Oct 03, 2025

Exagen Inc. (XGN) Reports Q1 Loss, Tops Revenue Estimates - MSN

Oct 03, 2025
pulisher
Oct 03, 2025

Is Exagen Inc. stock a bargain at current levelsQuarterly Investment Review & Real-Time Volume Spike Alerts - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

Will Exagen Inc. (E08A) stock recover faster than industryMarket Sentiment Review & Real-Time Volume Trigger Notifications - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

Is Exagen Inc. (E08A) stock supported by free cash flowJuly 2025 Levels & Technical Buy Zone Confirmations - newser.com

Oct 03, 2025

Exagen Inc Azioni (XGN) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Exagen Inc Azioni (XGN) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
NMSIC Co-Investment Fund, L.P.
10% Owner
Mar 25 '25
Sale
3.30
350,000
1,155,000
1,758,958
NMSIC Co-Investment Fund, L.P.
10% Owner
Nov 20 '24
Sale
3.30
200,000
660,040
2,108,958
Black Jeffrey G.
Chief Financial Officer
Nov 15 '24
Buy
2.98
22,298
66,448
274,492
ABALLI JOHN
President and CEO
Nov 14 '24
Buy
2.81
24,305
68,297
689,799
diagnostics_research WAT
$334.87
price up icon 0.74%
diagnostics_research DGX
$186.82
price down icon 0.28%
diagnostics_research LH
$283.71
price up icon 0.34%
$180.54
price up icon 0.62%
diagnostics_research MTD
$1,359.61
price up icon 4.26%
diagnostics_research IQV
$205.75
price up icon 1.29%
Capitalizzazione:     |  Volume (24 ore):